"Obstructive sleep apnea co-morbidity in patients with fibromyalgia: a " by Edwin S. Meresh, Hewa Artin et al.
 

Document Type

Article

Publication Date

4-29-2019

Publication Title

Open Access Rheumatology: Research and Reviews

Volume

11

Pages

1-7

Publisher Name

Dove Medical Press Limited

Abstract

Background: Fibromyalgia (FM) is a chronic medical condition characterized by widespread pain, sleep disturbance, and cognitive dysfunction. Sleep disorders are thought to play a prominent role in the etiology and symptomatic management of FM, specifically obstructive sleep apnea (OSA). In order to provide collaborative care, we need a better understanding of any overlapping presentation of FM and OSA. We conducted a site-wide review of patients from 2012–2016 to identify FM patients diagnosed with OSA.

Methods: Charts were reviewed in patients aged 18 and above from 2012–2016 using ICD codes from a clinical data repository. Intersection of patients with a diagnosis of FM and OSA in clinics of psychiatry, sleep, rheumatology, and other outpatient clinics was compared. Polysomnography order patterns for FM patients were investigated.

Results: Co-morbidity was highest in the sleep clinic (85.8%) compared to psychiatry (42.0%), rheumatology (18.7%), and other outpatient clinics (3.6%) (p< 0.001). In the rheumatology and other outpatient clinics, 93.5% and 96% of patients respectively, had no polysomnography ordered. Pairwise comparison of co-morbidity in clinics: sleep vs psychiatry, sleep vs rheumatology, sleep vs other clinics, psychiatry vs rheumatology, psychiatry vs other clinics, and rheumatology vs other clinics were statistically significant after applying a Sidak adjustment to the p-values (all p< 0.001).

Conclusion: Our analysis suggests that there could be a correlation between FM and OSA, and referral to sleep studies is recommended in the management of patients with FM. The varying prevalence of FM patients with co-morbid OSA in sleep clinics when compared to other outpatient clinics suggests a discrepancy in the identification of FM patients with OSA. When properly screened, OSA co-morbidity has the potential to be higher in other outpatient clinics.

Comments

Author Posting © The Author(s), 2019. This article is posted here by permission of Dove Medical Press Limited for personal use and non-commercial redistribution. This article was published open access in Open Access Rheumatology: Research and Reviews, Vol. 11 (April 29, 2019), https://doi.org/10.2147/OARRR.S196576.

Creative Commons License

Creative Commons Attribution-NonCommercial 4.0 International License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 17
  • Usage
    • Downloads: 2
  • Captures
    • Readers: 57
  • Mentions
    • News Mentions: 1
  • Social Media
    • Shares, Likes & Comments: 77
see details

Included in

Rheumatology Commons

Share

COinS